Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

503 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Design and rationale of a prospective, randomized, non-inferiority trial to determine the safety and efficacy of the Biolimus A9™ drug coated balloon for the treatment of in-stent restenosis: First-in-man trial (REFORM).
Traynor BP, Fitzgerald S, Alfonso F, O'Kane P, Sabaté M, Tölg R, Trevelyan J, Hahn JY, Mylotte D, Wöhrle J, Rai H, Cortese B, Morice MC, Schuette D, Copt S, Oldroyd KG, Byrne RA; REFORM investigators. Traynor BP, et al. Among authors: morice mc. Cardiovasc Revasc Med. 2023 Nov;56:75-81. doi: 10.1016/j.carrev.2023.06.004. Epub 2023 Jun 6. Cardiovasc Revasc Med. 2023. PMID: 37328392 Free article. Clinical Trial.
Mortality after multivessel revascularisation involving the proximal left anterior descending artery.
Ono M, Hara H, Gao C, Kawashima H, Wang R, O'Leary N, Wykrzykowska JJ, Piek JJ, Mack MJ, Holmes D, Morice MC, Head S, Kappetein AP, Noack T, Davierwala PM, Mohr FW, Garg S, Onuma Y, Serruys PW; SYNTAX Extended Survival Investigators. Ono M, et al. Among authors: morice mc. Heart. 2022 Oct 28;108(22):1784-1791. doi: 10.1136/heartjnl-2022-320934. Heart. 2022. PMID: 35732441 Free PMC article.
Comparing a strategy of sirolimus-eluting balloon treatment to drug-eluting stent implantation in de novo coronary lesions in all-comers: Design and rationale of the SELUTION DeNovo Trial.
Spaulding C, Krackhardt F, Bogaerts K, Urban P, Meis S, Morice MC, Eccleshall S. Spaulding C, et al. Among authors: morice mc. Am Heart J. 2023 Apr;258:77-84. doi: 10.1016/j.ahj.2023.01.007. Epub 2023 Jan 13. Am Heart J. 2023. PMID: 36642225 Free article. Clinical Trial.
First randomised controlled trial comparing the sirolimus-eluting bioadaptor with the zotarolimus-eluting drug-eluting stent in patients with de novo coronary artery lesions: 12-month clinical and imaging data from the multi-centre, international, BIODAPTOR-RCT.
Saito S, Bennett J, Nef HM, Webster M, Namiki A, Takahashi A, Kakuta T, Yamazaki S, Shibata Y, Scott D, Vrolix M, Menon M, Möllmann H, Werner N, Neylon A, Mehmedbegovic Z, Smits PC, Morice MC, Verheye S; BIOADAPTOR-RCT Collaborators. Saito S, et al. Among authors: morice mc. EClinicalMedicine. 2023 Oct 24;65:102304. doi: 10.1016/j.eclinm.2023.102304. eCollection 2023 Nov. EClinicalMedicine. 2023. PMID: 38106564 Free PMC article.
Impact of Baseline Left Ventricular Ejection Fraction on Mid-term Outcomes in Women Undergoing Transcatheter Aortic Valve Implantation: Insight from the WIN TAVI Registry.
Muro FMD, Vogel B, Sartori S, Tchetche D, Feng Y, Petronio AS, Mehilli J, Bay B, Gitto M, Lefevre T, Presbitero P, Capranzano P, Oliva A, Iadanza A, Sardella G, Van Mieghem N, Meliga E, Leone PP, Dumonteil N, Fraccaro C, Trabattoni D, Mikhail G, Ferrer-Gracia MC, Naber C, Sharma SK, Watanabe Y, Morice MC, Dangas G, Chieffo A, Mehran R. Muro FMD, et al. Among authors: morice mc. Am J Cardiol. 2024 Nov 8:S0002-9149(24)00789-6. doi: 10.1016/j.amjcard.2024.11.004. Online ahead of print. Am J Cardiol. 2024. PMID: 39522578
Validation of the Valve Academic Research Consortium High Bleeding Risk Definition in Patients Undergoing TAVR.
Avvedimento M, Cepas-Guillén P, Ternacle J, Urena M, Alperi A, Cheema A, Veiga G, Nombela-Franco L, Vilalta V, Esposito G, Campelo-Parada F, Indolfi C, Del Trigo M, Muñoz-Garcia A, Maneiro-Melón NM, Asmarats L, Regueiro A, Del Val D, Serra V, Auffret V, Modine T, Bonnet G, Mesnier J, Suc G, Avanzas P, Rezaei E, Fradejas-Sastre V, Tirado-Conte G, Fernandez-Nofrerias E, Franzone A, Guitteny T, Sorrentino S, Oteo JF, Nuche J, Gutiérrez-Alonso L, Flores Umanzor E, Alfonso F, Monastyrski A, Nolf M, Côté M, Mehran R, Morice MC, Capodanno D, Garot P, Rodés-Cabau J. Avvedimento M, et al. Among authors: morice mc. Circ Cardiovasc Interv. 2024 Oct 30. doi: 10.1161/CIRCINTERVENTIONS.124.014800. Online ahead of print. Circ Cardiovasc Interv. 2024. PMID: 39475194 Free article.
Definitions of adverse events associated with extracorporeal membrane oxygenation in children: results of an international Delphi process from the ECMO-CENTRAL ARC.
Alexander PMA, Di Nardo M, Combes A, Vogel AM, Antonini MV, Barrett N, Benedetti GM, Bettencourt A, Brodie D, Gómez-Gutiérrez R, Gorga SM, Hodgson C, Kapoor PM, Le J, MacLaren G, O'Neil ER, Ostermann M, Paden ML, Patel N, Rojas-Peña A, Said AS, Sperotto F, Willems A, Vercaemst L, Yoganathan AP, Lorts A, Del Nido PJ, Barbaro RP; Extracorporeal Life Support Organization (ELSO); International ECMO Network (ECMONet); Pediatric Acute Lung Injury and Sepsis Investigators (PALISI); Pediatric ECMO subgroup of PALISI and ELSO (PediECMO); European Society of Paediatric and Neonatal Intensive Care (ESPNIC); Australian and New Zealand Intensive Care Society Paediatric Study Group (ANZICS PSG); Intensive Care Society (ICS); Pediatric Cardiac Intensive Care Society (PCICS); Advanced Cardiac Therapies Improving Outcomes Network (ACTION); Children's Hospitals Neonatal Consortium (CHNC); American Pediatric Surgical Association (APSA); Society of Thoracic Surgeons (STS); Society of Critical Care Medicine (SCCM). Alexander PMA, et al. Lancet Child Adolesc Health. 2024 Oct;8(10):773-780. doi: 10.1016/S2352-4642(24)00132-9. Lancet Child Adolesc Health. 2024. PMID: 39299748 Review.
Clinical outcomes with thin versus thick strut polymer-free biolimus-coated stents at 3 years.
Eberli FR, Oldroyd KG, Urban P, Krucoff MW, Morice MC, Tanguay JF, Leon MB, Brunel P, Maillard L, Lipiecki J, Cook S, Berland J, Hovasse T, Carrié D, Schütte D, Sadozai Slama S, Garot P. Eberli FR, et al. Among authors: morice mc. Open Heart. 2024 Jun 18;11(1):e002679. doi: 10.1136/openhrt-2024-002679. Open Heart. 2024. PMID: 38890129 Free PMC article.
LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial.
Baumbach A, van Royen N, Amat-Santos IJ, Hudec M, Bunc M, Ijsselmuiden A, Laanmets P, Unic D, Merkely B, Hermanides RS, Ninios V, Protasiewicz M, Rensing BJWM, Martin PL, Feres F, De Sousa Almeida M, van Belle E, Linke A, Ielasi A, Montorfano M, Webster M, Toutouzas K, Teiger E, Bedogni F, Voskuil M, Pan M, Angerås O, Kim WK, Rothe J, Kristić I, Peral V, Garg S, Elzomor H, Tobe A, Morice MC, Onuma Y, Soliman O, Serruys PW; LANDMARK trial investigators. Baumbach A, et al. Among authors: morice mc. Lancet. 2024 Jun 22;403(10445):2695-2708. doi: 10.1016/S0140-6736(24)00821-3. Epub 2024 May 22. Lancet. 2024. PMID: 38795719 Clinical Trial.
Defining high bleeding risk in patients undergoing transcatheter aortic valve implantation: a VARC-HBR consensus document.
Garot P, Morice MC, Angiolillo DJ, Cabau JR, Park DW, Van Mieghem NM, Collet JP, Leon MB, Sengottuvelu G, Neylon A, Ten Berg JM, Mylotte D, Tchétché D, Krucoff MW, Reardon MJ, Piazza N, Mack MJ, Généreux P, Makkar R, Hayashida K, Ohno Y, Mochizuki S, Shirai Y, Matsumara R, Jin Y, Webb JG, Cutlip DE, Chen M, Spitzer E, Mehran R, Capodanno D. Garot P, et al. Among authors: morice mc. EuroIntervention. 2024 May 10;20(9):536-550. doi: 10.4244/EIJ-D-23-01020. EuroIntervention. 2024. PMID: 38726720 Free article.
503 results